Heron Therapeutics, Inc. (NASDAQ:HRTX) Q4 2025 Earnings Call Transcript February 26, 2026
Heron Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.01772, expectations were $-0.03.
Operator: Good day, and thank you for standing by. Welcome to the Heron Therapeutics Q4 2025 Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your first speaker today, Melissa Jarel, Executive...
